Cita APA (7a ed.)
VICKERS, J., CRAMER, P., EARDLEY-PATEL, R., & EXCELL, O. (2022). Overcoming Engineering Challenges to Enable Commercial-Scale mRNA Vaccine Manufacturing: This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities. BioPharm International, 35(8), 36-41.
Cita Chicago Style (17a ed.)
VICKERS, JULIE, PETER CRAMER, RANNA EARDLEY-PATEL, y OLIVER EXCELL. "Overcoming Engineering Challenges to Enable Commercial-Scale MRNA Vaccine Manufacturing: This Article Provides an Overview of Solutions to Address Key Challenges Facing Vaccine Developers or CDMOs Wishing to Build Their Own Commercial-scale MRNA Production Facilities." BioPharm International 35, no. 8 (2022): 36-41.
Cita MLA (9a ed.)
VICKERS, JULIE, et al. "Overcoming Engineering Challenges to Enable Commercial-Scale MRNA Vaccine Manufacturing: This Article Provides an Overview of Solutions to Address Key Challenges Facing Vaccine Developers or CDMOs Wishing to Build Their Own Commercial-scale MRNA Production Facilities." BioPharm International, vol. 35, no. 8, 2022, pp. 36-41.
Precaución: Estas citas no son 100% exactas.